BMY Rallies 16.2% in Three Months: Buy, Sell or Hold the Stock?

Bristol Myers Squibb's Growth Portfolio and pipeline support momentum, but generic headwinds and recent gains call for a cautious stance.

10.08.2026

Bristol Myers to build $2.3 billion manufacturing site in Houston

Drugmaker Bristol Myers Squibb on Monday said it will spend about $2.3 billion to build a new manufacturing facility in Houston, Texas, part of a previously announced $40 billion ‌commitment to invest in the United States.

10.08.2026

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #BMS--Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas.

06.08.2026

Bristol Myers (BMY) Moves to Buy: Rationale Behind the Upgrade

Bristol Myers (BMY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

05.08.2026

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

NEW YORK--(BUSINESS WIRE)-- #AgenticAI--Schrödinger, Inc. announced a strategic agreement with BMS to deploy Bunsen, Schrödinger's agentic AI co-scientist, within its research organization.

05.08.2026

'No discussions' over AstraZeneca-Bristol Myers deal, senior source says

There are "no discussions" ongoing between AstraZeneca and Bristol Myers Squibb over a potential ‌deal, a senior source close to the matter told Reuters on Wednesday, quashing the prospect of a mooted mega merger between the drugmakers.

04.08.2026

BMY or AMGN: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Bristol Myers Squibb (BMY) and Amgen (AMGN). But which of these two stocks is more attractive to value investors?

Videolar

No Data

There is no data to display

Reytinglar oshishi / pasayishi

Ticker	Tashkilot	Reyting o‘zgarishi	Maqsadli narx	Sana
BMY	Argus	Buy	undefined >> $75	August 5th 2026

Press-relizlar

10.08.2026

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #BMS--Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas.

Bristol-Myers Squibb Company (BMY)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Bristol-Myers Squibb Company (BMY)

BMY Rallies 16.2% in Three Months: Buy, Sell or Hold the Stock?

Bristol Myers to build $2.3 billion manufacturing site in Houston

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

Bristol Myers (BMY) Moves to Buy: Rationale Behind the Upgrade

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

'No discussions' over AstraZeneca-Bristol Myers deal, senior source says

BMY or AMGN: Which Is the Better Value Stock Right Now?

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

Search stocks

Bristol-Myers Squibb Company (BMY)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Bristol-Myers Squibb Company (BMY)

BMY Rallies 16.2% in Three Months: Buy, Sell or Hold the Stock?

Bristol Myers to build $2.3 billion manufacturing site in Houston

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

Bristol Myers (BMY) Moves to Buy: Rationale Behind the Upgrade

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

'No discussions' over AstraZeneca-Bristol Myers deal, senior source says

BMY or AMGN: Which Is the Better Value Stock Right Now?

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery